Carregant...
A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma
Sorafenib, a multikinase inhibitor, is the first and only drug, which improves significantly the overall survival in patients with advanced hepatocellular carcinoma (HCC). However, many patients experience diverse side effects, some of them severe and unexpected. To date, acute acalculous cholecysti...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Co., Limited
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3360105/ https://ncbi.nlm.nih.gov/pubmed/22645635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v4.i5.115 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|